Moreover, NAR specifically binds CRMP2 to reduce its phosphorylation [30], which might be hopeful to regulate central sensitization and deliver safe and non-opioid-dependent analgesia in RA chronic pain. The gene discussed is CPSF4; the disease is rheumatoid arthritis.